Incidence of acute mastoiditis in colorado children in the pneumococcal conjugate vaccine era

Pediatric Infectious Disease Journal

Volumn 33, Issue 5, 2014, Pages 453-457

  Halgrimson, Whitney R ^a   Chan, Kenny H ^a   Abzug, Mark J ^b   Perkins, Jonathan N ^a   Carosone Link, Phyllis ^c   Simões, Eric A F ^b,d  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Children's Hospital Colorado   (United States)

^d Global Health and Health Disparities   (United States)

Author keywords

conjugate; epidemiology; mastoiditis; pneumococcal; vaccine

Indexed keywords

PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; VACCINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASTOIDECTOMY; MASTOIDITIS; MEDICAL DOCUMENTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; EPIDEMIOLOGY; HOSPITAL; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

CHILD; COLORADO; HOSPITALS; HUMANS; INCIDENCE; INPATIENTS; MASTOIDITIS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84899112927     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000138     Document Type: Article

References (40)

1. Zhou F, Shefer A, Kong Y, et al. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics. 2008;121:253-260.
2. Huang SS, Johnson KM, Ray GT, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011;29:3398-3412.
3. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304:2161-2169.
4. Leibovitz E. Complicated otitis media and its implications. Vaccine. 2008;26(suppl 7):G16-G19.
5. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-9):1-35.
6. Jansen AGSC, Hak E, Veenhoven RH, et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev. 2009:CD001480.
7. Hanage WP, Finkelstein JA, Huang SS, et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics. 2010;2:80-84.
8. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772-1778.
9. American Academy of Pediatrics. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-65.
10. Neff MJ; American Academy of Pediatrics; American Academy of Family Physicians. AAP, AAFP release guideline on diagnosis and management of acute otitis media. Am Fam Physician. 2004;69:2713-2715.
11. Choudhuri JA, Ogden LG, Ruttenber AJ, et al. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics. 2006;117:349-356.
12. Centers for Disease Control and Prevention. National, state, and urban area vaccination levels among children aged 19-35 months-United States, 2002. MMWR 2003;52:728-732.
13. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2003. MMWR 2004;53:658-661.
14. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2004. MMWR 2005;54:717-721.
15. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2005. MMWR 2006;55:988-993.
16. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2006. MMWR 2007;56:880-885.
17. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2007. MMWR 2008;57:961-966.
18. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2008. MMWR 2009;58:921-926.
19. State of Colorado Department of Local Affairs. State of Colorado Population by Age and Gender. Updated November 1, 2011. Available at: https://dola. colorado.gov/demog-webapps/pag-category.jsf. Accessed January 31, 2012.
20. Rosner BA. Fundamentals of Biostatistics. 5th ed. Pacific Grove, CA: Duxbury Thompson Learning; 2000.
21. Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360:244-256.
22. Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med. 2010;16:217-225.
23. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784-1792.
24. Pavia M, Bianco A, Nobile CG, et al. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pediatrics. 2009;123:e1103-e1110.
25. Thorne MC, Chewaproug L, Elden LM. Suppurative complications of acute otitis media: changes in frequency over time. Arch Otolaryngol Head Neck Surg. 2009;135:638-641.
26. Choi SS, Lander L. Pediatric acute mastoiditis in the post-pneumococcal conjugate vaccine era. Laryngoscope. 2011;121:1072-1080.
27. Hoberman A, Paradise JL, Shaikh N, et al. Pneumococcal resistance and serotype 19A in Pittsburgh-area children with acute otitis media before and after introduction of 7-valent pneumococcal polysaccharide vaccine. Clin Pediatr (Phila). 2011;50:114-120.
28. Grubb MS, Spaugh DC. Microbiology of acute otitis media, Puget Sound region, 2005-2009. Clin Pediatr (Phila). 2010;49:727-730.
29. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010;29:304-309.
30. Huang SS, Hinrichsen VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1-e11.
31. Techasaensiri C, Messina AF, Katz K, et al. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Pediatr Infect Dis J. 2010;29:294-300.
32. Kyaw MH, Lynfield R, Schaffner W, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med. 2006;354:1455-1463.
33. Lee GM, Huang SS, Rifas-Shiman SL, et al. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis. 2009;9:110.
34. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302:758-766.
35. Coco A, Vernacchio L, Horst M, et al. Management of acute otitis media after publication of the 2004 AAP and AAFP clinical practice guideline. Pediatrics. 2010;125:214-220.
36. Stenfeldt K, Hermansson A. Acute mastoiditis in southern Sweden: a study of occurrence and clinical course of acute mastoiditis before and after introduction of new treatment recommendations for AOM. Eur Arch Otorhinolaryngol. 2010;267:1855-1861.
37. Thompson PL, Gilbert RE, Long PF, et al. Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database. Pediatrics. 2009;123:424-430.
38. Ho D, Rotenberg BW, Berkowitz RG. The relationship between acute mastoiditis and antibiotic use for acute otitis media in children. Arch Otolaryngol Head Neck Surg. 2008;134:45-48.
39. Pritchett CV, Thorne MC. Incidence of pediatric acute mastoiditis: 1997-2006. Arch Otolaryngol Head Neck Surg. 2012;138:451-455.
40. Colorado Hospital Association. Colorado Hospitals by the Numbers. Available at: http://www.cha.com/pdfs/Colorado-Hospitals-Fact-Sheet.pdf. Accessed September 29, 2013.